{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T16:05:27Z","timestamp":1786982727611,"version":"build-2736575974"},"reference-count":102,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,19]],"date-time":"2025-11-19T00:00:00Z","timestamp":1763510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,11,19]],"date-time":"2025-11-19T00:00:00Z","timestamp":1763510400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","award":["1K23DK131322"],"award-info":[{"award-number":["1K23DK131322"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Pediatr Rep"],"DOI":"10.1007\/s40124-025-00364-8","type":"journal-article","created":{"date-parts":[[2025,11,19]],"date-time":"2025-11-19T04:18:54Z","timestamp":1763525934000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Metabolic Implications of PCOS"],"prefix":"10.1007","volume":"13","author":[{"given":"Amna","family":"Naveed","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachana","family":"Shah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angelina","family":"Bernier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valeriia","family":"Muradova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eray Savgan","family":"Gurol","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melanie","family":"Cree","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachel","family":"Whooten","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,19]]},"reference":[{"issue":"4","key":"364_CR1","doi-asserted-by":"publisher","first-page":"S15","DOI":"10.1093\/ejendo\/lvae125","volume":"191","author":"ACH Neven","year":"2024","unstructured":"Neven ACH, Forslund M, Ranashinha S, Mousa A, Tay CT, Pe\u00f1a A, et al. Prevalence and accurate diagnosis of polycystic ovary syndrome in adolescents across world regions: a systematic review and meta-analysis. Eur J Endocrinol. 2024;191(4):S15\u201327.","journal-title":"Eur J Endocrinol"},{"key":"364_CR2","doi-asserted-by":"publisher","DOI":"10.1093\/ejendo\/lvad096","author":"HJ Teede","year":"2023","unstructured":"Teede HJ, Tay CT, Laven JJEL, Dokras A, Moran LJ, Piltonen TT, et al. Recommendations from the 2023 international evidence-based guideline for the assessment and management of polycystic ovary syndrome. J Clin Endocrinol Metab. 2023;108(10):2447\u20132469. https:\/\/doi.org\/10.1093\/ejendo\/lvad096","journal-title":"Eur J Endocrinol"},{"issue":"6","key":"364_CR3","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1159\/000479371","volume":"88","author":"L Ib\u00e1\u00f1ez","year":"2017","unstructured":"Ib\u00e1\u00f1ez L, Oberfield SE, Witchel S, Auchus RJ, Chang RJ, Codner E, et al. An international consortium update: pathophysiology, diagnosis, and treatment of polycystic ovarian syndrome in adolescence. Horm Res Paediatr. 2017;88(6):371\u201395.","journal-title":"Horm Res Paediatr"},{"issue":"5","key":"364_CR4","doi-asserted-by":"publisher","first-page":"748","DOI":"10.1093\/humupd\/dmu012","volume":"20","author":"JA Barry","year":"2014","unstructured":"Barry JA, Azizia MM, Hardiman PJ. Risk of endometrial, ovarian and breast cancer in women with polycystic ovary syndrome: a systematic review and meta-analysis. Hum Reprod Update. 2014;20(5):748\u201358.","journal-title":"Hum Reprod Update"},{"key":"364_CR5","doi-asserted-by":"crossref","unstructured":"dga.Henney AE, Gillespiec CS, Lai JYM, Schofield P, Riley DR, Caleyachetty R, et al. Risk of type 2 diabetes, MASLD and cardiovascular disease in people living with polycystic ovary syndrome. J Clin Endocrinol Metab. 2025;110(5):1235\u20131246.","DOI":"10.1210\/clinem\/dgae481"},{"issue":"1","key":"364_CR6","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1093\/humrep\/deh098","volume":"19","author":"ESHRE Rotterdam","year":"2004","unstructured":"Rotterdam ESHRE, ASRM-Sponsored PCOS consensus workshop group. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS). Hum Reprod Oxf Engl. 2004;19(1):41\u20137.","journal-title":"Hum Reprod Oxf Engl"},{"issue":"6","key":"364_CR7","doi-asserted-by":"publisher","first-page":"e1003132","DOI":"10.1371\/journal.pmed.1003132","volume":"17","author":"M Dapas","year":"2020","unstructured":"Dapas M, Lin FTJ, Nadkarni GN, Sisk R, Legro RS, Urbanek M, et al. Distinct subtypes of polycystic ovary syndrome with novel genetic associations: an unsupervised, phenotypic clustering analysis. Myers JE, editor. PLOS Med. 2020;17(6):e1003132.","journal-title":"PLOS Med"},{"issue":"2","key":"364_CR8","doi-asserted-by":"publisher","DOI":"10.1210\/jendso\/bvad169","volume":"8","author":"A Chen-Patterson","year":"2024","unstructured":"Chen-Patterson A, Bernier A, Burgert T, Davis V, Khan T, Geller D, et al. Distinct reproductive phenotypes segregate with differences in body weight in adolescent polycystic ovary syndrome. J Endocr Soc. 2024;8(2):bvad169.","journal-title":"J Endocr Soc"},{"issue":"4","key":"364_CR9","doi-asserted-by":"publisher","DOI":"10.1210\/jendso\/bvab008","volume":"5","author":"S Andrisse","year":"2021","unstructured":"Andrisse S, Garcia-Reyes Y, Pyle L, Kelsey MM, Nadeau KJ, Cree-Green M. Racial and ethnic differences in metabolic disease in adolescents with obesity and polycystic ovary syndrome. J Endocr Soc. 2021;5(4):bvab008.","journal-title":"J Endocr Soc"},{"issue":"4","key":"364_CR10","doi-asserted-by":"publisher","first-page":"e1827","DOI":"10.1210\/clinem\/dgz285","volume":"105","author":"S Simon","year":"2020","unstructured":"Simon S, Rahat H, Carreau AM, Garcia-Reyes Y, Halbower A, Pyle L, et al. Poor sleep is related to metabolic syndrome severity in adolescents with PCOS and obesity. J Clin Endocrinol Metab. 2020;105(4):e1827\u201334.","journal-title":"J Clin Endocrinol Metab"},{"issue":"9468","key":"364_CR11","doi-asserted-by":"publisher","first-page":"1415","DOI":"10.1016\/S0140-6736(05)66378-7","volume":"365","author":"RH Eckel","year":"2005","unstructured":"Eckel RH, Grundy SM, Zimmet PZ. The metabolic syndrome. Lancet Lond Engl. 2005;365(9468):1415\u201328.","journal-title":"Lancet Lond Engl"},{"issue":"4","key":"364_CR12","doi-asserted-by":"publisher","first-page":"600","DOI":"10.1007\/s00125-009-1620-4","volume":"53","author":"RK Simmons","year":"2010","unstructured":"Simmons RK, Alberti KGMM, Gale EaM, Colagiuri S, Tuomilehto J, Qiao Q, et al. The metabolic syndrome: useful concept or clinical tool? Report of a WHO expert consultation. Diabetologia. 2010;53(4):600\u20135.","journal-title":"Diabetologia"},{"issue":"2","key":"364_CR13","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1016\/j.jpeds.2007.07.056","volume":"152","author":"ES Ford","year":"2008","unstructured":"Ford ES, Li C. Defining the metabolic syndrome in children and adolescents: will the real definition please stand up? J Pediatr. 2008;152(2):160\u2013e16413.","journal-title":"J Pediatr"},{"issue":"1","key":"364_CR14","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1038\/s41366-020-00713-1","volume":"45","author":"C Reisinger","year":"2021","unstructured":"Reisinger C, Nkeh-Chungag BN, Fredriksen PM, Goswami N. The prevalence of pediatric metabolic syndrome-a critical look on the discrepancies between definitions and its clinical importance. Int J Obes. 2021;45(1):12\u201324.","journal-title":"Int J Obes"},{"issue":"2","key":"364_CR15","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1210\/jc.2005-1666","volume":"91","author":"AD Coviello","year":"2006","unstructured":"Coviello AD, Legro RS, Dunaif A. Adolescent girls with polycystic ovary syndrome have an increased risk of the metabolic syndrome associated with increasing androgen levels independent of obesity and insulin resistance. J Clin Endocrinol Metab. 2006;91(2):492\u20137.","journal-title":"J Clin Endocrinol Metab"},{"issue":"12","key":"364_CR16","doi-asserted-by":"publisher","first-page":"4780","DOI":"10.1210\/jc.2008-1198","volume":"93","author":"B Rossi","year":"2008","unstructured":"Rossi B, Sukalich S, Droz J, Griffin A, Cook S, Blumkin A, et al. Prevalence of metabolic syndrome and related characteristics in obese adolescents with and without polycystic ovary syndrome. J Clin Endocrinol Metab. 2008;93(12):4780\u20136.","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"364_CR17","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1080\/09513590802630146","volume":"25","author":"F Fruzzetti","year":"2009","unstructured":"Fruzzetti F, Perini D, Lazzarini V, Parrini D, Genazzani AR. Hyperandrogenemia influences the prevalence of the metabolic syndrome abnormalities in adolescents with the polycystic ovary syndrome. Gynecol Endocrinol. 2009;25(5):335\u201343.","journal-title":"Gynecol Endocrinol"},{"issue":"6","key":"364_CR18","doi-asserted-by":"publisher","first-page":"1093","DOI":"10.1530\/EJE-10-0205","volume":"162","author":"R Alemzadeh","year":"2010","unstructured":"Alemzadeh R, Kichler J, Calhoun M. Spectrum of metabolic dysfunction in relationship with hyperandrogenemia in obese adolescent girls with polycystic ovary syndrome. Eur J Endocrinol. 2010;162(6):1093\u20139.","journal-title":"Eur J Endocrinol"},{"issue":"7","key":"364_CR19","doi-asserted-by":"publisher","first-page":"2347","DOI":"10.1016\/j.fertnstert.2011.03.001","volume":"95","author":"R Hart","year":"2011","unstructured":"Hart R, Doherty DA, Mori T, Huang RC, Norman RJ, Franks S, et al. Extent of metabolic risk in adolescent girls with features of polycystic ovary syndrome. Fertil Steril. 2011;95(7):2347\u2013e23531.","journal-title":"Fertil Steril"},{"key":"364_CR20","first-page":"377","volume-title":"Polycystic ovary syndrome","author":"J Zawadski","year":"1992","unstructured":"Zawadski J, Dunaif A. Diagnostic criteria for polycystic ovary syndrome: towards a rational approach. In: Polycystic ovary syndrome. Boston: Blackwell Scientific; 1992. p. 377\u201384."},{"issue":"8","key":"364_CR21","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1001\/archpedi.157.8.821","volume":"157","author":"S Cook","year":"2003","unstructured":"Cook S, Weitzman M, Auinger P, Nguyen M, Dietz WH. Prevalence of a metabolic syndrome phenotype in adolescents: findings from the third National health and nutrition examination Survey, 1988\u20131994. Arch Pediatr Adolesc Med. 2003;157(8):821\u20137.","journal-title":"Arch Pediatr Adolesc Med"},{"issue":"16","key":"364_CR22","doi-asserted-by":"publisher","first-page":"2494","DOI":"10.1161\/01.CIR.0000145117.40114.C7","volume":"110","author":"SD de Ferranti","year":"2004","unstructured":"de Ferranti SD, Gauvreau K, Ludwig DS, Neufeld EJ, Newburger JW, Rifai N. Prevalence of the metabolic syndrome in American adolescents: findings from the third National health and nutrition examination survey. Circulation. 2004;110(16):2494\u20137.","journal-title":"Circulation"},{"issue":"17","key":"364_CR23","doi-asserted-by":"publisher","first-page":"2735","DOI":"10.1161\/CIRCULATIONAHA.105.169404","volume":"112","author":"SM Grundy","year":"2005","unstructured":"Grundy SM, Cleeman JI, Daniels SR, Donato KA, Eckel RH, Franklin BA, et al. Diagnosis and management of the metabolic syndrome: an American Heart Association\/National Heart, Lung, and Blood Institute scientific statement. Circulation. 2005;112(17):2735\u201352.","journal-title":"Circulation"},{"issue":"5","key":"364_CR24","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1111\/j.1399-5448.2007.00271.x","volume":"8","author":"P Zimmet","year":"2007","unstructured":"Zimmet P, Alberti KGM, Kaufman F, Tajima N, Silink M, Arslanian S, et al. The metabolic syndrome in children and adolescents - an IDF consensus report. Pediatr Diabetes. 2007;8(5):299\u2013306.","journal-title":"Pediatr Diabetes"},{"issue":"23","key":"364_CR25","doi-asserted-by":"publisher","first-page":"2362","DOI":"10.1056\/NEJMoa031049","volume":"350","author":"R Weiss","year":"2004","unstructured":"Weiss R, Dziura J, Burgert TS, Tamborlane WV, Taksali SE, Yeckel CW, et al. Obesity and the metabolic syndrome in children and adolescents. N Engl J Med. 2004;350(23):2362\u201374.","journal-title":"N Engl J Med"},{"issue":"2","key":"364_CR26","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1016\/j.fertnstert.2013.04.001","volume":"100","author":"SB Christensen","year":"2013","unstructured":"Christensen SB, Black MH, Smith N, Martinez MM, Jacobsen SJ, Porter AH, et al. Prevalence of polycystic ovary syndrome in adolescents. Fertil Steril. 2013;100(2):470\u20137.","journal-title":"Fertil Steril"},{"issue":"6","key":"364_CR27","doi-asserted-by":"publisher","first-page":"1168","DOI":"10.1093\/humrep\/dead053","volume":"38","author":"LJ Dobbie","year":"2023","unstructured":"Dobbie LJ, Pittam B, Zhao SS, Alam U, Hydes TJ, Barber TM, et al. Childhood, adolescent, and adulthood adiposity are associated with risk of PCOS: a Mendelian randomization study with meta-analysis. Hum Reprod. 2023;38(6):1168\u201382.","journal-title":"Hum Reprod"},{"issue":"3","key":"364_CR28","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1159\/000515294","volume":"14","author":"J Aarestrup","year":"2021","unstructured":"Aarestrup J, Pedersen DC, Thomas PE, Glintborg D, Holm JC, Bjerregaard LG, et al. Birthweight, childhood body mass index, height and growth, and risk of polycystic ovary syndrome. Obes Facts. 2021;14(3):283\u201390.","journal-title":"Obes Facts"},{"issue":"5","key":"364_CR29","doi-asserted-by":"publisher","first-page":"e2023064894","DOI":"10.1542\/peds.2023-064894","volume":"153","author":"RC Whooten","year":"2024","unstructured":"Whooten RC, Rifas-Shiman SL, Perng W, Chavarro JE, Taveras E, Oken E, et al. Associations of childhood adiposity and cardiometabolic biomarkers with adolescent PCOS. Pediatrics. 2024;153(5):e2023064894.","journal-title":"Pediatrics"},{"issue":"9","key":"364_CR30","doi-asserted-by":"publisher","first-page":"1486","DOI":"10.1002\/oby.21935","volume":"25","author":"F de Zegher","year":"2017","unstructured":"de Zegher F, Reinehr T, Malpique R, Darendeliler F, L\u00f3pez-Bermejo A, Ib\u00e1\u00f1ez L. Reduced prenatal weight gain and\/or augmented postnatal weight gain precedes polycystic ovary syndrome in adolescent girls. Obesity. 2017;25(9):1486\u20139.","journal-title":"Obesity"},{"issue":"7","key":"364_CR31","first-page":"1370","volume":"43","author":"E Koivuaho","year":"2019","unstructured":"Koivuaho E, Laru J, Ojaniemi M, Puukka K, Kettunen J, Tapanainen JS, et al. Age at adiposity rebound in childhood is associated with PCOS diagnosis and obesity in adulthood\u2014longitudinal analysis of BMI data from birth to age 46 in cases of PCOS. Int J Obes 2005. 2019;43(7):1370\u20139.","journal-title":"Int J Obes 2005"},{"key":"364_CR32","doi-asserted-by":"publisher","first-page":"697223","DOI":"10.3389\/fendo.2021.697223","volume":"12","author":"S Zhu","year":"2021","unstructured":"Zhu S, Li Z, Hu C, Sun F, Wang C, Yuan H, et al. Imaging-based body fat distribution in polycystic ovary syndrome: a systematic review and meta-analysis. Front Endocrinol. 2021;12:697223.","journal-title":"Front Endocrinol"},{"issue":"6","key":"364_CR33","doi-asserted-by":"publisher","first-page":"1358","DOI":"10.1016\/S0015-0282(03)00265-6","volume":"79","author":"B Yildirim","year":"2003","unstructured":"Yildirim B, Sabir N, Kaleli B. Relation of intra-abdominal fat distribution to metabolic disorders in nonobese patients with polycystic ovary syndrome. Fertil Steril. 2003;79(6):1358\u201364.","journal-title":"Fertil Steril."},{"key":"364_CR34","doi-asserted-by":"crossref","unstructured":"Barber TM, Golding SJ, Alvey C, Wass JAH, Karpe F, Franks S, et al. Global adiposity rather than abnormal regional fat distribution characterizes women with polycystic ovary syndrome. J Clin Endocrinol Metab. 2008;93(3):999\u20131004.","DOI":"10.1210\/jc.2007-2117"},{"issue":"6","key":"364_CR35","doi-asserted-by":"publisher","first-page":"1495","DOI":"10.1093\/humrep\/der070","volume":"26","author":"JG Dolfing","year":"2011","unstructured":"Dolfing JG, Stassen CM, van Haard PMM, Wolffenbuttel BHR, Schweitzer DH. Comparison of MRI-assessed body fat content between lean women with polycystic ovary syndrome (PCOS) and matched controls: less visceral fat with PCOS. Hum Reprod Oxf Engl. 2011;26(6):1495\u2013500.","journal-title":"Hum Reprod Oxf Engl."},{"issue":"3","key":"364_CR36","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1016\/j.bbalip.2009.12.006","volume":"1801","author":"S Virtue","year":"2010","unstructured":"Virtue S, Vidal-Puig A. Adipose tissue expandability, lipotoxicity and the Metabolic Syndrome\u2013an allostatic perspective. Biochim Biophys Acta. 2010;1801(3):338\u201349.","journal-title":"Biochim Biophys Acta."},{"issue":"2","key":"364_CR37","doi-asserted-by":"publisher","first-page":"E304","DOI":"10.1210\/jc.2010-1290","volume":"96","author":"L Manner\u00e5\u00e5s-Holm","year":"2011","unstructured":"Manner\u00e5\u00e5s-Holm L, Leonhardt H, Kullberg J, Jennische E, Od\u00e9\u00e9n A, Holm G, et al. Adipose tissue has aberrant morphology and function in PCOS: enlarged adipocytes and low serum adiponectin, but not circulating sex steroids, are strongly associated with insulin resistance. J Clin Endocrinol Metab. 2011;96(2):E304\u2013311.","journal-title":"J Clin Endocrinol Metab."},{"key":"364_CR38","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.steroids.2017.12.009","volume":"130","author":"B Echibur\u00fa\u00fa","year":"2018","unstructured":"Echibur\u00fa\u00fa B, P\u00e9\u00e9rez-Bravo F, Galgani JE, Sandoval D, Sald\u00ed\u00edas C, Crisosto N, et al. Enlarged adipocytes in subcutaneous adipose tissue associated to hyperandrogenism and visceral adipose tissue volume in women with polycystic ovary syndrome. Steroids. 2018;130:15\u201321.","journal-title":"Steroids."},{"issue":"9","key":"364_CR39","doi-asserted-by":"publisher","first-page":"920","DOI":"10.1016\/j.steroids.2013.05.001","volume":"78","author":"G Chazenbalk","year":"2013","unstructured":"Chazenbalk G, Singh P, Irge D, Shah A, Abbott DH, Dumesic DA. Androgens inhibit adipogenesis during human adipose stem cell commitment to predipocyte formation. Steroids. 2013;78(9):920\u20136.","journal-title":"Steroids."},{"key":"364_CR40","doi-asserted-by":"crossref","unstructured":"Siemienowicz KJ, Coukan F, Franks S, Rae MT, Duncan WC. Aberrant subcutaneous adipogenesis precedes adult metabolic dysfunction in an ovine model of polycystic ovary syndrome (PCOS). Mol Cell Endocrinol. 2021;519.","DOI":"10.1016\/j.mce.2020.111042"},{"issue":"3","key":"364_CR41","doi-asserted-by":"publisher","first-page":"262","DOI":"10.7861\/clinmedicine.16-3-262","volume":"16","author":"TM Barber","year":"2016","unstructured":"Barber TM, Dimitriadis GK, Andreou A, Franks S. Polycystic ovary syndrome: insight into pathogenesis and a common association with insulin resistance. Clin Med. 2016;16(3):262\u20136.","journal-title":"Clin Med"},{"key":"364_CR42","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1146\/annurev.me.36.020185.002241","volume":"36","author":"CR Kahn","year":"1985","unstructured":"Kahn CR. The molecular mechanism of insulin action. Annu Rev Med. 1985;36:429\u201351.","journal-title":"Annu Rev Med"},{"issue":"1","key":"364_CR43","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1210\/edrv-6-1-45","volume":"6","author":"RN Bergman","year":"1985","unstructured":"Bergman RN, Finegood DT, Ader M. Assessment of insulin sensitivity in Vivo *. Endocr Rev. 1985;6(1):45\u201386.","journal-title":"Endocr Rev"},{"issue":"7","key":"364_CR44","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1016\/j.molmed.2006.05.006","volume":"12","author":"E Diamanti-Kandarakis","year":"2006","unstructured":"Diamanti-Kandarakis E, Papavassiliou AG. Molecular mechanisms of insulin resistance in polycystic ovary syndrome. Trends Mol Med. 2006;12(7):324\u201332.","journal-title":"Trends Mol Med"},{"issue":"5","key":"364_CR45","doi-asserted-by":"publisher","first-page":"1039","DOI":"10.1016\/j.fertnstert.2008.02.091","volume":"89","author":"AA Bremer","year":"2008","unstructured":"Bremer AA, Miller WL. The serine phosphorylation hypothesis of polycystic ovary syndrome: a unifying mechanism for hyperandrogenemia and insulin resistance. Fertil Steril. 2008;89(5):1039\u201348.","journal-title":"Fertil Steril"},{"issue":"4","key":"364_CR46","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1016\/S0889-8529(18)30245-7","volume":"20","author":"JE Nestler","year":"1991","unstructured":"Nestler JE, Strauss JF. Insulin as an effector of human ovarian and adrenal steroid metabolism. Endocrinol Metab Clin North Am. 1991;20(4):807\u201323.","journal-title":"Endocrinol Metab Clin North Am"},{"issue":"1","key":"364_CR47","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1172\/JCI113864","volume":"83","author":"A Dunaif","year":"1989","unstructured":"Dunaif A, Graf M. Insulin administration alters gonadal steroid metabolism independent of changes in gonadotropin secretion in insulin-resistant women with the polycystic ovary syndrome. J Clin Invest. 1989;83(1):23\u20139.","journal-title":"J Clin Invest"},{"issue":"12","key":"364_CR48","doi-asserted-by":"publisher","first-page":"1132","DOI":"10.2337\/diacare.14.12.1132","volume":"14","author":"P Bj\u00f6rntorp","year":"1991","unstructured":"Bj\u00f6rntorp P. Metabolic implications of body fat distribution. Diabetes Care. 1991;14(12):1132\u201343.","journal-title":"Diabetes Care"},{"issue":"Suppl 2","key":"364_CR49","doi-asserted-by":"publisher","first-page":"S59","DOI":"10.1038\/sj.ijo.0801280","volume":"24","author":"G De Pergola","year":"2000","unstructured":"De Pergola G. The adipose tissue metabolism: role of testosterone and dehydroepiandrosterone. Int J Obes Relat Metab Disord J Int Assoc Study Obes. 2000;24(Suppl 2):S59\u201363.","journal-title":"Int J Obes Relat Metab Disord J Int Assoc Study Obes"},{"key":"364_CR50","doi-asserted-by":"publisher","unstructured":"Tian Y, Li J, Su S, Cao Y, Wang Z, Zhao S et al. PCOS-GWAS Susceptibility Variants in THADA, INSR, TOX3, and DENND1A Are Associated With Metabolic Syndrome or Insulin Resistance in Women With PCOS. Front Endocrinol [Internet]. 2020 Apr 30 [cited 2025 Apr 22];11. Available from: https:\/\/www.frontiersin.orghttps:\/\/www.frontiersin.org\/journals\/endocrinology\/articles\/https:\/\/doi.org\/10.3389\/fendo.2020.00274\/full","DOI":"10.3389\/fendo.2020.00274\/full"},{"issue":"8","key":"364_CR51","doi-asserted-by":"publisher","first-page":"e1005455","DOI":"10.1371\/journal.pgen.1005455","volume":"11","author":"MR Jones","year":"2015","unstructured":"Jones MR, Brower MA, Xu N, Cui J, Mengesha E, Chen YDI, et al. Systems genetics reveals the functional context of PCOS loci and identifies genetic and molecular mechanisms of disease heterogeneity. PLoS Genet. 2015;11(8):e1005455.","journal-title":"PLoS Genet"},{"issue":"1","key":"364_CR52","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.jpag.2015.06.004","volume":"29","author":"N Coles","year":"2016","unstructured":"Coles N, Bremer K, Kives S, Zhao X, Hamilton J. Utility of the oral glucose tolerance test to assess glucose abnormalities in adolescents with polycystic ovary syndrome. J Pediatr Adolesc Gynecol. 2016;29(1):48\u201352.","journal-title":"J Pediatr Adolesc Gynecol"},{"key":"364_CR53","unstructured":"Palmert MR, Gordon CM, Kartashov AI, Legro RS, Emans SJ, Dunaif A. Screening for Abnormal Glucose Tolerance in Adolescents with Polycystic Ovary Syndrome."},{"issue":"1","key":"364_CR54","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1111\/j.1399-5448.2012.00902.x","volume":"14","author":"CA Flannery","year":"2013","unstructured":"Flannery CA, Rackow B, Cong X, Duran E, Selen DJ, Burgert TS. Polycystic ovary syndrome in adolescence: impaired glucose tolerance occurs across the spectrum of BMI: IGT in adolescent polycystic ovary syndrome. Pediatr Diabetes. 2013;14(1):42\u20139.","journal-title":"Pediatr Diabetes"},{"issue":"3","key":"364_CR55","doi-asserted-by":"publisher","first-page":"e496","DOI":"10.1542\/peds.2008-2050","volume":"124","author":"MM Nur","year":"2009","unstructured":"Nur MM, Newman IM, Siqueira LM. Glucose metabolism in overweight Hispanic adolescents with and without polycystic ovary syndrome. Pediatrics. 2009;124(3):e496\u2013502.","journal-title":"Pediatrics"},{"issue":"10","key":"364_CR56","doi-asserted-by":"publisher","first-page":"4682","DOI":"10.1210\/jc.2003-030617","volume":"88","author":"ME Silfen","year":"2003","unstructured":"Silfen ME, Denburg MR, Manibo AM, Lobo RA, Jaffe R, Ferin M, et al. Early endocrine, metabolic, and sonographic characteristics of polycystic ovary syndrome (PCOS): comparison between nonobese and obese adolescents. J Clin Endocrinol Metab. 2003;88(10):4682\u20138.","journal-title":"J Clin Endocrinol Metab"},{"issue":"7","key":"364_CR57","doi-asserted-by":"publisher","first-page":"468","DOI":"10.3109\/09513590.2010.492886","volume":"27","author":"S Angioni","year":"2011","unstructured":"Angioni S, Sanna S, Magnini R, Melis GB, Fulghesu AM. The quantitative insulin sensitivity check index is not able to detect early metabolic alterations in young patients with polycystic ovarian syndrome. Gynecol Endocrinol. 2011;27(7):468\u201374.","journal-title":"Gynecol Endocrinol"},{"issue":"8","key":"364_CR58","doi-asserted-by":"publisher","first-page":"1938","DOI":"10.1038\/oby.2008.336","volume":"16","author":"K H\u00fccking","year":"2008","unstructured":"H\u00fccking K, Watanabe RM, Stefanovski D, Bergman RN. OGTT-derived measures of insulin sensitivity are confounded by factors other than insulin sensitivity itself. Obesity. 2008;16(8):1938\u201345.","journal-title":"Obesity"},{"issue":"3","key":"364_CR59","doi-asserted-by":"publisher","first-page":"1273","DOI":"10.1210\/jc.2003-031205","volume":"89","author":"E Diamanti-Kandarakis","year":"2004","unstructured":"Diamanti-Kandarakis E, Kouli C, Alexandraki K, Spina G. Failure of mathematical indices to accurately assess insulin resistance in lean, overweight, or obese women with polycystic ovary syndrome. J Clin Endocrinol Metab. 2004;89(3):1273\u20136.","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"364_CR60","first-page":"284","volume":"19","author":"R Mortada","year":"2013","unstructured":"Mortada R, Comerford K, Kallail KJ, Karakas SE. Utility of hemoglobin-A1C in nondiabetic women with polycystic ovary syndrome. Endocr Pract Off J Am Coll Endocrinol Am Assoc Clin Endocrinol. 2013;19(2):284\u20139.","journal-title":"Endocr Pract Off J Am Coll Endocrinol Am Assoc Clin Endocrinol"},{"key":"364_CR61","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1016\/j.jpeds.2019.07.031","volume":"216","author":"MM Kelsey","year":"2020","unstructured":"Kelsey MM, Zeitler PS, Drews K, Chan CL. Normal hemoglobin A1c variability in early adolescence: adult criteria for prediabetes should be applied with caution. J Pediatr. 2020;216:232\u20135.","journal-title":"J Pediatr"},{"issue":"6","key":"364_CR62","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1203\/01.pdr.0000246097.73031.27","volume":"60","author":"TS Hannon","year":"2006","unstructured":"Hannon TS, Janosky J, Arslanian SA. Longitudinal study of physiologic insulin resistance and metabolic changes of puberty. Pediatr Res. 2006;60(6):759\u201363.","journal-title":"Pediatr Res"},{"issue":"7","key":"364_CR63","doi-asserted-by":"publisher","first-page":"931","DOI":"10.1210\/js.2017-00192","volume":"1","author":"M Cree-Green","year":"2017","unstructured":"Cree-Green M, Rahat H, Newcomer BR, Bergman BC, Brown MS, Coe GV, et al. Insulin resistance, hyperinsulinemia, and mitochondria dysfunction in nonobese girls with polycystic ovarian syndrome. J Endocr Soc. 2017;1(7):931\u201344.","journal-title":"J Endocr Soc"},{"issue":"2","key":"364_CR64","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1210\/jcem-54-2-254","volume":"54","author":"AH Kissebah","year":"1982","unstructured":"Kissebah AH, Vydelingum N, Murray R, Evans DJ, Hartz AJ, Kalkhoff RK, et al. Relation of body fat distribution to metabolic complications of obesity. J Clin Endocrinol Metab. 1982;54(2):254\u201360.","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"364_CR65","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1067\/mpd.2001.109603","volume":"138","author":"VD Lewy","year":"2001","unstructured":"Lewy VD, Danadian K, Witchel SF, Arslanian S. Early metabolic abnormalities in adolescent girls with polycystic ovarian syndrome. J Pediatr. 2001;138(1):38\u201344.","journal-title":"J Pediatr"},{"issue":"1","key":"364_CR66","first-page":"66","volume":"86","author":"SA Arslanian","year":"2001","unstructured":"Arslanian SA, Lewy VD, Danadian K. Glucose intolerance in obese adolescents with polycystic ovary syndrome: roles of insulin resistance and \u03b2-cell dysfunction and risk of cardiovascular disease1. J Clin Endocrinol Metab. 2001;86(1):66\u201371.","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"364_CR67","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1016\/j.jadohealth.2009.10.008","volume":"46","author":"A Fulghesu","year":"2010","unstructured":"Fulghesu A, Magnini R, Portoghese E, Angioni S, Minerba L, Melis GB. Obesity-related lipid profile and altered insulin incretion in adolescents with polycystic ovary syndrome. J Adolesc Health. 2010;46(5):474\u201381.","journal-title":"J Adolesc Health"},{"issue":"9","key":"364_CR68","doi-asserted-by":"publisher","first-page":"E726","DOI":"10.1152\/ajpendo.00619.2014","volume":"308","author":"M Cree-Green","year":"2015","unstructured":"Cree-Green M, Newcomer BR, Coe G, Newnes L, Baumgartner A, Brown MS, et al. Peripheral insulin resistance in obese girls with hyperandrogenism is related to oxidative phosphorylation and elevated serum free fatty acids. Am J Physiol-Endocrinol Metab. 2015;308(9):E726\u201333.","journal-title":"Am J Physiol-Endocrinol Metab"},{"issue":"5","key":"364_CR69","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1530\/EJE-13-1035","volume":"170","author":"E Lerchbaum","year":"2014","unstructured":"Lerchbaum E, Schwetz V, Giuliani A, Obermayer-Pietsch B. Influence of a positive family history of both type 2 diabetes and PCOS on metabolic and endocrine parameters in a large cohort of PCOS women. Eur J Endocrinol. 2014;170(5):727\u201339.","journal-title":"Eur J Endocrinol"},{"issue":"8","key":"364_CR70","doi-asserted-by":"publisher","first-page":"1823","DOI":"10.1093\/humrep\/deae124","volume":"39","author":"D Glintborg","year":"2024","unstructured":"Glintborg D, Ollila MM, M\u00f8ller JJK, Pesonen P, Persson S, Elenis E, et al. Prospective risk of type 2 diabetes in 99 892 nordic women with polycystic ovary syndrome and 446 055 controls: national cohort study from Denmark, Finland, and Sweden. Hum Reprod. 2024;39(8):1823\u201334.","journal-title":"Hum Reprod"},{"issue":"4","key":"364_CR71","doi-asserted-by":"publisher","first-page":"560","DOI":"10.2337\/dc18-1738","volume":"42","author":"NS Kakoly","year":"2019","unstructured":"Kakoly NS, Earnest A, Teede HJ, Moran LJ, Joham AE. The impact of obesity on the incidence of type 2 diabetes among women with polycystic ovary syndrome. Diabetes Care. 2019;42(4):560\u20137.","journal-title":"Diabetes Care"},{"issue":"10","key":"364_CR72","doi-asserted-by":"publisher","first-page":"3848","DOI":"10.1210\/jc.2017-01354","volume":"102","author":"KH Rubin","year":"2017","unstructured":"Rubin KH, Glintborg D, Nybo M, Abrahamsen B, Andersen M. Development and risk factors of type 2 diabetes in a nationwide population of women with polycystic ovary syndrome. J Clin Endocrinol Metab. 2017;102(10):3848\u201357.","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"364_CR73","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1093\/humrep\/dew329","volume":"32","author":"MME Ollila","year":"2017","unstructured":"Ollila MME, West S, Kein\u00e4nen-Kiukaanniemi S, Jokelainen J, Auvinen J, Puukka K, et al. Overweight and obese but not normal weight women with PCOS are at increased risk of type 2 diabetes mellitus\u2014a prospective, population-based cohort study. Hum Reprod. 2017;32(2):423\u201331.","journal-title":"Hum Reprod"},{"issue":"9","key":"364_CR74","doi-asserted-by":"publisher","first-page":"3251","DOI":"10.1210\/jc.2012-1690","volume":"97","author":"CL Morgan","year":"2012","unstructured":"Morgan CL, Jenkins-Jones S, Currie CJ, Rees DA. Evaluation of adverse outcome in young women with polycystic ovary syndrome versus matched, reference controls: a retrospective, observational study. J Clin Endocrinol Metab. 2012;97(9):3251\u201360.","journal-title":"J Clin Endocrinol Metab"},{"issue":"9","key":"364_CR75","doi-asserted-by":"publisher","first-page":"2369","DOI":"10.2337\/db11-1360","volume":"61","author":"A Gambineri","year":"2012","unstructured":"Gambineri A, Patton L, Altieri P, Pagotto U, Pizzi C, Manzoli L, et al. Polycystic ovary syndrome is a risk factor for type 2 diabetes. Diabetes. 2012;61(9):2369\u201374.","journal-title":"Diabetes"},{"issue":"1","key":"364_CR76","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1007\/s11892-006-0056-1","volume":"6","author":"MY Boudreaux","year":"2006","unstructured":"Boudreaux MY, Talbott EO, Kip KE, Brooks MM, Witchel SF. Risk of T2DM and impaired fasting glucose among Pcos subjects: results of an 8-year follow-up. Curr Diab Rep. 2006;6(1):77\u201383.","journal-title":"Curr Diab Rep"},{"issue":"5","key":"364_CR77","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1111\/pedi.13206","volume":"22","author":"J Hudnut-Beumler","year":"2021","unstructured":"Hudnut-Beumler J, Kaar JL, Taylor A, Kelsey MM, Nadeau KJ, Zeitler P, et al. Development of type 2 diabetes in adolescent girls with polycystic ovary syndrome and obesity. Pediatr Diabetes. 2021;22(5):699\u2013706.","journal-title":"Pediatr Diabetes"},{"key":"364_CR78","doi-asserted-by":"publisher","DOI":"10.1016\/j.diabres.2023.110640","volume":"199","author":"NYH Ng","year":"2023","unstructured":"Ng NYH, Wu H, Lau ESH, Zhang X, Yang A, Tsang AYT, et al. Young-onset diabetes in women with polycystic ovary syndrome: a territory-wide retrospective analysis in Hong Kong. Diabetes Res Clin Pract. 2023;199:110640.","journal-title":"Diabetes Res Clin Pract"},{"key":"364_CR79","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1016\/j.jpeds.2015.09.082","volume":"168","author":"KS Hughan","year":"2016","unstructured":"Hughan KS, Tfayli H, Warren-Ulanch JG, Barinas-Mitchell E, Arslanian SA. Early biomarkers of subclinical atherosclerosis in obese adolescent girls with polycystic ovary syndrome. J Pediatr. 2016;168:104\u2013e1111.","journal-title":"J Pediatr"},{"issue":"2","key":"364_CR80","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1016\/j.amepre.2024.10.009","volume":"68","author":"S Zhang","year":"2025","unstructured":"Zhang S, Darbinian JA, Greenspan LC, Naderi S, Ramalingam ND, Lo JC. Hypertensive blood pressure in adolescent females with polycystic ovary syndrome. Am J Prev Med. 2025;68(2):408\u201311.","journal-title":"Am J Prev Med"},{"issue":"1","key":"364_CR81","first-page":"55","volume":"16","author":"D Macut","year":"2020","unstructured":"Macut D, Mladenovi\u0107 V, Bjeki\u0107-Macut J, Livadas S, Stanojlovi\u0107 O, Hrn\u010di\u0107 D, et al. Hypertension in polycystic ovary syndrome: novel insights. Curr Hypertens Rev. 2020;16(1):55\u201360.","journal-title":"Curr Hypertens Rev"},{"key":"364_CR82","doi-asserted-by":"crossref","unstructured":"Vine D, Wang Y, Jetha M, Ball G, Proctor S. Impaired ApoB-Lipoprotein and Triglyceride Metabolism in Obese Adolescents with Polycystic Ovary Syndrome. J Clin Endocrinol Metab. 2016;jc.2016\u20132854.","DOI":"10.1210\/jc.2016-2854"},{"key":"364_CR83","unstructured":"Taskomur A, Ula\u015f \u00d6. Relationship of inflammatory and metabolic parameters in adolescents with PCOS: BMI matched case-control study. Arch Endocrinol Metab [Internet]. 2022 [cited 2025 Apr 10];66(3). Available from: https:\/\/avesis.ksbu.edu.tr\/yayin\/a5351953-637c-4d22-a435-e5ddd8a6f63b\/relationship-of-inflammatory-and-metabolic-parameters-in-adolescents-with-pcos-bmi-matched-case-control-study"},{"key":"364_CR84","doi-asserted-by":"crossref","unstructured":"European Society for Pediatric Gastroenterology, Hepatology and Nutrition (ESPGHAN), European Association for the Study of the Liver (EASL), North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition (NASPGHAN), Latin-American Society for Pediatric Gastroenterology, Hepatology, and Nutrition (LASPGHAN), Asian Pan\u2010Pacific Society for Pediatric Gastroenterology, Hepatology and Nutrition (APPSPGHAN), Pan Arab Society for Pediatric Gastroenterology and Nutrition (PASPGHAN), et al. Paediatric steatotic liver disease has unique characteristics: A multisociety statement endorsing the new nomenclature. J Pediatr Gastroenterol Nutr et al. 2024;78(5):1190\u20136.","DOI":"10.1002\/jpn3.12156"},{"issue":"39","key":"364_CR85","doi-asserted-by":"publisher","first-page":"14172","DOI":"10.3748\/wjg.v20.i39.14172","volume":"20","author":"CE Kelley","year":"2014","unstructured":"Kelley CE, Brown AJ, Diehl AM, Setji TL. Review of nonalcoholic fatty liver disease in women with polycystic ovary syndrome. World J Gastroenterol. 2014;20(39):14172\u201384.","journal-title":"World J Gastroenterol"},{"issue":"11","key":"364_CR86","doi-asserted-by":"publisher","first-page":"1403","DOI":"10.1111\/apt.14058","volume":"45","author":"JJ Kim","year":"2017","unstructured":"Kim JJ, Kim D, Yim JY, Kang JH, Han KH, Kim SM, et al. Polycystic ovary syndrome with hyperandrogenism as a risk factor for non-obese non-alcoholic fatty liver disease. Aliment Pharmacol Ther. 2017;45(11):1403\u201312.","journal-title":"Aliment Pharmacol Ther"},{"issue":"3","key":"364_CR87","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1016\/j.aohep.2020.01.004","volume":"19","author":"N Salva-Pastor","year":"2020","unstructured":"Salva-Pastor N, L\u00f3pez-S\u00e1nchez GN, Ch\u00e1vez-Tapia NC, Audifred-Salom\u00f3n JR, Niebla-C\u00e1rdenas D, Topete-Estrada R, et al. Polycystic ovary syndrome with feasible equivalence to overweight as a risk factor for non-alcoholic fatty liver disease development and severity in Mexican population. Ann Hepatol. 2020;19(3):251\u20137.","journal-title":"Ann Hepatol"},{"issue":"5","key":"364_CR88","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1016\/j.jpag.2009.03.003","volume":"22","author":"E Barfield","year":"2009","unstructured":"Barfield E, Liu YH, Kessler M, Pawelczak M, David R, Shah B. The prevalence of abnormal liver enzymes and metabolic syndrome in obese adolescent females with polycystic ovary syndrome. J Pediatr Adolesc Gynecol. 2009;22(5):318\u201322.","journal-title":"J Pediatr Adolesc Gynecol"},{"issue":"11","key":"364_CR89","doi-asserted-by":"publisher","first-page":"2399","DOI":"10.1002\/oby.21651","volume":"24","author":"M Cree-Green","year":"2016","unstructured":"Cree-Green M, Bergman BC, Coe GV, Newnes L, Baumgartner AD, Bacon S, et al. Hepatic steatosis is common in adolescents with obesity and PCOS and relates to de novo lipogenesis but not insulin resistance. Obesity. 2016;24(11):2399\u2013406.","journal-title":"Obesity"},{"issue":"5","key":"364_CR90","doi-asserted-by":"publisher","first-page":"980","DOI":"10.1111\/jgh.13241","volume":"31","author":"OT Ayonrinde","year":"2016","unstructured":"Ayonrinde OT, Adams LA, Doherty DA, Mori TA, Beilin LJ, Oddy WH, et al. Adverse metabolic phenotype of adolescent girls with non-alcoholic fatty liver disease plus polycystic ovary syndrome compared with other girls and boys. J Gastroenterol Hepatol. 2016;31(5):980\u20137.","journal-title":"J Gastroenterol Hepatol"},{"issue":"5","key":"364_CR91","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1515\/jpem-2022-0527","volume":"36","author":"N Patel-Sanchez","year":"2023","unstructured":"Patel-Sanchez N, Perito E, Tsai P, Raymond-Flesch M, Lodish M, Sarkar M. Prevalence of nonalcoholic fatty liver disease increased with type 2 diabetes mellitus in overweight\/obese youth with polycystic ovary syndrome. J Pediatr Endocrinol Metab JPEM. 2023;36(5):441\u20136.","journal-title":"J Pediatr Endocrinol Metab JPEM"},{"issue":"1","key":"364_CR92","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1210\/clinem\/dgab658","volume":"107","author":"C Falzarano","year":"2022","unstructured":"Falzarano C, Lofton T, Osei-Ntansah A, Oliver T, Southward T, Stewart S, et al. Nonalcoholic fatty liver disease in women and girls with polycystic ovary syndrome. J Clin Endocrinol Metab. 2022;107(1):258\u201372.","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"364_CR93","doi-asserted-by":"publisher","first-page":"1745","DOI":"10.1016\/j.fertnstert.2013.08.015","volume":"100","author":"SF Michaliszyn","year":"2013","unstructured":"Michaliszyn SF, Lee S, Tfayli H, Arslanian S. Polycystic ovary syndrome and nonalcoholic fatty liver in obese adolescents: association with metabolic risk profile. Fertil Steril. 2013;100(6):1745\u201351.","journal-title":"Fertil Steril"},{"issue":"8","key":"364_CR94","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1007\/BF03345743","volume":"32","author":"G Targher","year":"2009","unstructured":"Targher G, Solagna E, Tosi F, Castello R, Spiazzi G, Zoppini G, et al. Abnormal serum alanine aminotransferase levels are associated with impaired insulin sensitivity in young women with polycystic ovary syndrome. J Endocrinol Invest. 2009;32(8):695\u2013700.","journal-title":"J Endocrinol Invest"},{"issue":"1","key":"364_CR95","doi-asserted-by":"publisher","first-page":"e0245219","DOI":"10.1371\/journal.pone.0245219","volume":"16","author":"B Jobira","year":"2021","unstructured":"Jobira B, Frank DN, Silveira LJ, Pyle L, Kelsey MM, Garcia-Reyes Y, et al. Hepatic steatosis relates to gastrointestinal microbiota changes in obese girls with polycystic ovary syndrome. PLoS ONE. 2021;16(1):e0245219.","journal-title":"PLoS ONE"},{"issue":"1","key":"364_CR96","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1186\/s12916-025-03901-w","volume":"23","author":"AS Pe\u00f1a","year":"2025","unstructured":"Pe\u00f1a AS, Witchel SF, Boivin J, Burgert TS, Ee C, Hoeger KM, et al. International evidence-based recommendations for polycystic ovary syndrome in adolescents. BMC Med. 2025;23(1):151.","journal-title":"BMC Med"},{"issue":"6","key":"364_CR97","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1123\/ijsnem.2013-0232","volume":"25","author":"L Haqq","year":"2015","unstructured":"Haqq L, McFarlane J, Dieberg G, Smart N. The effect of lifestyle intervention on body composition, glycemic control, and cardiorespiratory fitness in polycystic ovarian syndrome: a systematic review and meta-analysis. Int J Sport Nutr Exerc Metab. 2015;25(6):533\u201340.","journal-title":"Int J Sport Nutr Exerc Metab"},{"issue":"11","key":"364_CR98","doi-asserted-by":"publisher","first-page":"3533","DOI":"10.1210\/jc.2011-1609","volume":"96","author":"N Lass","year":"2011","unstructured":"Lass N, Kleber M, Winkel K, Wunsch R, Reinehr T. Effect of lifestyle intervention on features of polycystic ovarian syndrome, metabolic syndrome, and intima-media thickness in obese adolescent girls. J Clin Endocrinol Metab. 2011;96(11):3533\u201340.","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"364_CR99","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1186\/s12902-020-00552-1","volume":"20","author":"S Abdolahian","year":"2020","unstructured":"Abdolahian S, Tehrani FR, Amiri M, Ghodsi D, Yarandi RB, Jafari M, et al. Effect of lifestyle modifications on anthropometric, clinical, and biochemical parameters in adolescent girls with polycystic ovary syndrome: a systematic review and meta-analysis. BMC Endocr Disord. 2020;20(1):71.","journal-title":"BMC Endocr Disord"},{"issue":"5","key":"364_CR100","doi-asserted-by":"publisher","first-page":"e20154089","DOI":"10.1542\/peds.2015-4089","volume":"137","author":"RA Al Khalifah","year":"2016","unstructured":"Al Khalifah RA, Florez ID, Dennis B, Thabane L, Bassilious E. Metformin or oral contraceptives for adolescents with polycystic ovarian syndrome: a meta-analysis. Pediatrics. 2016;137(5):e20154089.","journal-title":"Pediatrics"},{"issue":"8","key":"364_CR101","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1515\/JPEM.2005.18.8.761","volume":"18","author":"HF Allen","year":"2005","unstructured":"Allen HF, Mazzoni C, Heptulla RA, Murray MA, Miller N, Koenigs L, et al. Randomized controlled trial evaluating response to Metformin versus standard therapy in the treatment of adolescents with polycystic ovary syndrome. J Pediatr Endocrinol Metab. 2005;18(8):761\u20138.","journal-title":"J Pediatr Endocrinol Metab"},{"issue":"8","key":"364_CR102","doi-asserted-by":"publisher","first-page":"e2695","DOI":"10.1210\/clinem\/dgaa285","volume":"105","author":"H Cena","year":"2020","unstructured":"Cena H, Chiovato L, Nappi RE, Obesity. Polycystic ovary Syndrome, and infertility: A new avenue for GLP-1 receptor agonists. J Clin Endocrinol Metab. 2020;105(8):e2695\u2013709.","journal-title":"J Clin Endocrinol Metab"}],"container-title":["Current Pediatrics Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40124-025-00364-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40124-025-00364-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40124-025-00364-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,19]],"date-time":"2025-11-19T05:08:01Z","timestamp":1763528881000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40124-025-00364-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,19]]},"references-count":102,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["364"],"URL":"https:\/\/doi.org\/10.1007\/s40124-025-00364-8","relation":{},"ISSN":["2167-4841"],"issn-type":[{"value":"2167-4841","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,19]]},"assertion":[{"value":"15 September 2025","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 November 2025","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"35"}}